viernes, 30 de junio de 2017

Ivanhoe's Top 5 Reports This Week


CLEVELAND, Ohio (Ivanhoe Newswire) — Diabetes can be deadly. Each year, more than 70,000 Americans die from complications of the disease. About half of all people with type 2 diabetes don’t have their condition under control. Now, new research shows a well-known procedure for weight loss may be the best bet for patients with uncontrolled diabetes.

MIAMI, Fla. (Ivanhoe Newswire) — Imagine waking up not being able to hear out of one ear? Sudden hearing loss happens more than you think, and most people mistake it for a head cold. Getting help quickly could save your hearing.

New Treatment for CMS (2nd Week)

COLUMBUS, Ohio (Ivanhoe Newswire) — It’s called congenital myasthenic syndrome, or CMS. CMS causes muscle weakness and fatigue. It is often difficult to diagnose, and tough to treat. Now, researchers are testing a new treatment designed to give patients their lives back.

PHILADELPHIA, PA. (Ivanhoe Newswire) — Cancer patients routinely endure surgical biopsies to diagnose and detect progression of the disease. Now researchers have a non-invasive diagnostic tool called a liquid biopsy that replaces cutting. This non-invasive procedure finds the cancer wherever it is hiding in the body.

TAMPA, Fla. (Ivanhoe Newswire) — Two-hundred, fifty-three thousand women will be diagnosed this year with invasive breast cancer, and for women battling advanced forms of the disease, there’s now a new treatment. Doctors are calling it a first line of defense for advanced breast cancer.

Give the gift of health news!

Click here to sign up your friends and loved ones for the 

First to Know Newsletter!

More Medical News for this week:

PNES Mimics Epilepsy

The ABC’s of Preschool Depression

Quote of the week:

Stand up to hypocrisy. If you don’t, the hypocrites will teach. Stand up to ignorance, because if you let the ignorant run free, they will spread ignorance like a disease. Stand up for truth, because if you don’t, there will be no truth to your existence.” 

Suzy Kassem

Website Information:

Content Licensing:

No hay comentarios:

Publicar un comentario